Biofidelity Ltd, the cancer diagnostics company, today announces the opening of its US headquarters in Research Triangle Park, North Carolina, expanding its presence in the key US market ahead of its first product launch later this year. The location will house a state-of-the-art clinical cancer diagnostic laboratory that will perform the new ASPYRE-Lung assay for oncologists, pathologists, laboratories and pharmaceutical companies using Biofidelity’s break-through ASPYRE technology. Read more